Trial Profile
Exploratory Study of OPC-12759 Ophthalmic Suspension in Patients With Keratoconjunctiva Epithelial Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2018
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary) ; Hyaluronic acid
- Indications Keratoconjunctivitis sicca
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 19 Apr 2014 New trial record